Graham Capital Management L.P. Acquires New Stake in Doximity, Inc. (NASDAQ:DOCS)

Graham Capital Management L.P. acquired a new stake in Doximity, Inc. (NASDAQ:DOCS) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 33,661 shares of the company’s stock, valued at approximately $1,797,000.

Several other institutional investors have also bought and sold shares of DOCS. Global Retirement Partners LLC lifted its position in shares of Doximity by 468.1% during the fourth quarter. Global Retirement Partners LLC now owns 534 shares of the company’s stock worth $29,000 after acquiring an additional 440 shares in the last quarter. UMB Bank n.a. lifted its position in shares of Doximity by 69.1% during the fourth quarter. UMB Bank n.a. now owns 575 shares of the company’s stock worth $31,000 after acquiring an additional 235 shares in the last quarter. Larson Financial Group LLC lifted its position in shares of Doximity by 49.4% during the fourth quarter. Larson Financial Group LLC now owns 756 shares of the company’s stock worth $40,000 after acquiring an additional 250 shares in the last quarter. Optimum Investment Advisors purchased a new stake in shares of Doximity during the fourth quarter worth $43,000. Finally, Kapitalo Investimentos Ltda purchased a new stake in shares of Doximity during the fourth quarter worth $50,000. Hedge funds and other institutional investors own 87.19% of the company’s stock.

Doximity Stock Down 0.4%

DOCS opened at $59.10 on Monday. The stock has a market cap of $11.03 billion, a PE ratio of 59.10, a P/E/G ratio of 4.10 and a beta of 1.41. Doximity, Inc. has a 52 week low of $22.96 and a 52 week high of $85.21. The business’s fifty day simple moving average is $57.99 and its 200 day simple moving average is $57.36.

Insider Activity at Doximity

In other Doximity news, CFO Anna Bryson sold 45,000 shares of the company’s stock in a transaction dated Thursday, May 1st. The shares were sold at an average price of $57.23, for a total transaction of $2,575,350.00. Following the completion of the sale, the chief financial officer now directly owns 357,165 shares in the company, valued at $20,440,552.95. This represents a 11.19% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Kira Scherer Wampler sold 2,000 shares of the company’s stock in a transaction dated Thursday, May 1st. The shares were sold at an average price of $56.93, for a total transaction of $113,860.00. Following the sale, the director now owns 16,618 shares of the company’s stock, valued at approximately $946,062.74. The trade was a 10.74% decrease in their ownership of the stock. The disclosure for this sale can be found here. 37.40% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on DOCS shares. Canaccord Genuity Group increased their target price on Doximity from $60.00 to $71.00 and gave the stock a “hold” rating in a research report on Friday, February 7th. Raymond James restated an “outperform” rating and set a $83.00 target price (up previously from $65.00) on shares of Doximity in a research report on Friday, February 7th. The Goldman Sachs Group increased their target price on Doximity from $58.00 to $80.00 and gave the stock a “neutral” rating in a research report on Monday, February 10th. Needham & Company LLC upped their price target on shares of Doximity from $65.00 to $82.00 and gave the stock a “buy” rating in a report on Friday, February 7th. Finally, Morgan Stanley decreased their price target on shares of Doximity from $71.00 to $60.00 and set an “equal weight” rating on the stock in a report on Thursday, April 24th. Eleven research analysts have rated the stock with a hold rating, eight have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $65.39.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.